Os IFAs, IFAs, também conhecidos como ingredientes farmacêuticos activos, são preparados por síntese química, extractos de plantas ou biotecnologia, mas não podem ser consumidos directamente pelos pacientes.
mensagem|
API |
|
|
Product Name |
CAS No. |
|
1-Chloromethyl Naphathalene |
86-52-2 |
|
3,4-Dihydroxy-5-nitrobenzaldehyde |
116313-85-0 |
|
5-Nitro Vaniline |
6635-20-7 |
|
6-Methyl-2-(4-methyl phenyl)imidazo[1,2-a}pyridine-3-acetic acid |
189005-44-5 |
|
Atrovastatin Calcium |
134523-03-8 |
|
Enoxacin |
84294-96-2 |
|
Ethambutol DiHcl |
1070-11-7 |
|
Levetiracetam |
102767-28-2 |
|
Lexofloxacin |
100986-85-4 |
|
Metamizole Sodium |
5907-38-0 |
|
N,N-Diethyl-2-yanoacetamide |
26391-06-0 |
|
Norfloxacin |
70458-96-7 |
|
Oxolinic Acid |
14698-29-4 |
|
Rosuvastatin Calcium |
147098-20-2 |
|
(S）-IndolIne-2 --carboxylic Acid |
79815-20-6 |
|
API |
|
|
Product Name |
CAS No. |
|
1-Chloromethyl Naphathalene |
86-52-2 |
|
3,4-Dihydroxy-5-nitrobenzaldehyde |
116313-85-0 |
|
5-Nitro Vaniline |
6635-20-7 |
|
6-Methyl-2-(4-methyl phenyl)imidazo[1,2-a}pyridine-3-acetic acid |
189005-44-5 |
|
Atrovastatin Calcium |
134523-03-8 |
|
Enoxacin |
84294-96-2 |
|
Ethambutol DiHcl |
1070-11-7 |
|
Levetiracetam |
102767-28-2 |
|
Lexofloxacin |
100986-85-4 |
|
Metamizole Sodium |
5907-38-0 |
|
N,N-Diethyl-2-yanoacetamide |
26391-06-0 |
|
Norfloxacin |
70458-96-7 |
|
Oxolinic Acid |
14698-29-4 |
|
Rosuvastatin Calcium |
147098-20-2 |
|
(S）-IndolIne-2 --carboxylic Acid |
79815-20-6 |
